Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q6UC88
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q6UC88-F1 | Predicted | AlphaFoldDB |
25 variants for Q6UC88
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs134821996 | 30 | I>L | No | EVA | |
rs452141209 | 39 | M>V | No | EVA | |
rs475431631 | 41 | V>A | No | EVA | |
rs437604621 | 44 | V>G | No | EVA | |
rs457612834 | 57 | A>S | No | EVA | |
rs443181689 | 86 | S>G | No | EVA | |
rs469848507 | 162 | L>M | No | EVA | |
rs519785581 | 185 | A>V | No | EVA | |
rs523374902 | 188 | L>P | No | EVA | |
rs801282579 | 211 | A>T | No | EVA | |
rs722954404 | 212 | V>I | No | EVA | |
rs797303452 | 218 | S>L | No | EVA | |
rs458724404 | 244 | A>V | No | EVA | |
rs476648124 | 248 | F>V | No | EVA | |
rs435459203 | 253 | G>V | No | EVA | |
rs455664505 | 257 | C>G | No | EVA | |
rs472352299 | 261 | R>G | No | EVA | |
rs443846963 | 262 | Y>C | No | EVA | |
rs463813650 | 270 | N>Y | No | EVA | |
rs459728965 | 283 | V>A | No | EVA | |
rs479899890 | 287 | K>Q | No | EVA | |
rs445096975 | 296 | E>D | No | EVA | |
rs465223077 | 300 | M>I | No | EVA | |
rs519977580 | 303 | T>M | No | EVA | |
rs436916380 | 305 | E>D | No | EVA |
No associated diseases with Q6UC88
6 regional properties for Q6UC88
Type | Name | Position | InterPro Accession |
---|---|---|---|
conserved_site | Helix-turn-helix motif | 154 - 179 | IPR000047 |
domain | Homeobox domain | 123 - 187 | IPR001356 |
conserved_site | Homeobox, conserved site | 158 - 181 | IPR017970 |
domain | Homeobox domain, metazoa | 147 - 158 | IPR020479-1 |
domain | Homeobox domain, metazoa | 162 - 181 | IPR020479-2 |
domain | Distal-less-like homeobox protein, N-terminal domain | 28 - 104 | IPR022135 |
Functions
2 GO annotations of cellular component
Name | Definition |
---|---|
integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
3 GO annotations of molecular function
Name | Definition |
---|---|
cargo receptor activity | Binding specifically to a substance (cargo) to deliver it to a transport vesicle. Cargo receptors span a membrane (either the plasma membrane or a vesicle membrane), binding simultaneously to cargo molecules and coat adaptors, to efficiently recruit soluble proteins to nascent vesicles. |
hyaluronic acid binding | Binding to hyaluronic acid, a polymer composed of repeating dimeric units of glucuronic acid and N-acetyl glucosamine. |
transmembrane signaling receptor activity | Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction. |
4 GO annotations of biological process
Name | Definition |
---|---|
cell adhesion | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. |
hyaluronan catabolic process | The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine. |
positive regulation of cellular extravasation | Any process that activates or increases the frequency, rate, or extent of cellular extravasation. |
receptor-mediated endocytosis | An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles. |
4 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q9Y5Y7 | LYVE1 | Lymphatic vessel endothelial hyaluronic acid receptor 1 | Homo sapiens (Human) | PR |
P98066 | TNFAIP6 | Tumor necrosis factor-inducible gene 6 protein | Homo sapiens (Human) | PR |
Q8BHC0 | Lyve1 | Lymphatic vessel endothelial hyaluronic acid receptor 1 | Mus musculus (Mouse) | PR |
O08859 | Tnfaip6 | Tumor necrosis factor-inducible gene 6 protein | Mus musculus (Mouse) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MAKFFSLGLL | LASIWTTRLL | VQGSLRSEEI | SILGPCRIMG | VTLVTKKTQP | LLNFTEAQEA |
70 | 80 | 90 | 100 | 110 | 120 |
CRLVGLTLAS | QDQVEEARKF | GFETCSYGWV | KNQFVVIPRI | ISNPKCGKSG | VGVVIWRSSL |
130 | 140 | 150 | 160 | 170 | 180 |
SSRHRSYCHN | SSDIWINSCL | PEIITTDDPL | FNTETATYTT | KLMVSDSTHS | ELSTDGPDYV |
190 | 200 | 210 | 220 | 230 | 240 |
TTTVAPPLAS | TSTPRKRKLI | CITEAFMDTS | AVATERESDI | QNRPAFKNEA | VGFGGVPTAL |
250 | 260 | 270 | 280 | 290 | 300 |
LVLALLFFAA | AAGLAVCYVK | RYVKAFPFTN | KNQQKEMIET | KVVKEEKADD | SNPNEESKKM |
310 | 320 | ||||
NKTPEEPKSP | PKTTVRCLEA | EV |